ECM
HRMY icon

EMC Capital Management’s Harmony Biosciences HRMY Stock Holding History

EMC Capital Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$196K Sell
5,248
-926
-15% -$30.4K 0.09% 76
2025
Q3 		$170K Hold
6,174
– – 0.08% 116
2025
Q2 		$195K Buy
+6,174
New +$199K 0.11% 79

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EMC Capital Management's HRMY Position: Q4 2025 in Review

EMC Capital Management reduced its Harmony Biosciences (HRMY) stake by 15% in Q4 2025, selling an estimated $30.4K and leaving 5,248 shares worth $196K. The position accounts for 0.09% of the portfolio, ranked #76.

EMC Capital Management first reported a position in HRMY in Q2 2025 and has held it in 3 quarters since. 323 funds tracked by Wall St. Rank hold HRMY as of Q4 2025.

  • EMC Capital Management held 5,248 shares of Harmony Biosciences worth $196K as of Q4 2025.
  • EMC Capital Management sold 926 Harmony Biosciences shares in Q4 2025, an estimated $30.4K.
  • Harmony Biosciences made up 0.09% of EMC Capital Management's portfolio in Q4 2025, its #76 holding.
  • EMC Capital Management first reported a position in Harmony Biosciences in Q2 2025 and has held it in 3 quarters since.
  • 323 funds tracked by Wall St. Rank held Harmony Biosciences as of Q4 2025.

Based on EMC Capital Management's 13F filing for Q4 2025, filed 9 Mar 2026.